Urology News and Research

Latest Urology News and Research

Study reveals that male factor infertility is associated with a number of medical comorbidities

The December issue of European Urology, the official journal of the European Association of Urology, features an article entitled 'Are Infertile Men Less Healthy than Fertile Men? Results of a Prospective Case-Control Survey' by Dr. Andrea Salonia et al. The conclusion is that male factor infertility is associated with a number of medical comorbidities, as objectively scored with the hospital-based Charlson Comorbidity Index.

10 Nov 2009

New technique to identify patients more likely to survive advanced melanoma

Although the chances of surviving advanced melanoma aren't very good with current therapies, some patients can live for years with cancer that has spread beyond the skin to other organs. Now it may be possible to identify which patients are more likely to survive by analyzing the activity of hundreds of genes involved in the immune response and gene proliferation, according to researchers at NYU Langone Medical Center.

10 Nov 2009

Scientific article supports AEterna Zentaris' development of perifosine inhibitor

AEterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced publication of a scientific article in the renowned Journal of Urology, supporting the development of the Company's PI3K/Akt pathway inhibitor oral compound, perifosine, for the treatment of cancer.

9 Nov 2009

Warner Chilcott reports a net income of $424.2M for the quarter ended September 30, 2009

Warner Chilcott plc today announced its results for the quarter ended September 30, 2009. Revenue in the quarter ended September 30, 2009 increased 9.0% to $252.8 million over the prior year quarter. The primary drivers of the increase in revenue in the quarter were the net sales of LOESTRIN 24 FE and ESTRACE Cream which were partially offset by net sales declines of other products, primarily TACLONEX.

9 Nov 2009

Cook Medical to feature a series of product demonstrations in Tokyo, Japan

In an ongoing effort to drive innovation in endourology, Cook Medical will feature a series of product demonstrations with a special emphasis on the PERC NCircle® Nitinol Tipless Stone Extractor, Flexor® Ureteral Access Sheath and the Ultraxx™ Nephrostomy Balloon at the 23rd Congress of the Japanese Society of Endourology and ESWL (extracorporeal shock wave lithotripsy), in Tokyo, Japan.

9 Nov 2009

Changes in PSA over time aid prostate cancer detection

The November issue of European Urology, the official journal of the European Association of Urology, features an article focussing on prostate specific antigen (PSA) velocity and early cancer detection. It has been suggested that changes in PSA over time aid prostate cancer detection.

6 Nov 2009

Combination therapy before prostate removal may prevent recurrence of cancer

Researchers in the Oregon Health & Science University Knight Cancer Institute and the Portland Veterans Affairs Medical Center have found a combination of radiation therapy and chemotherapy given before prostate removal is safe and may have the potential to reduce cancer recurrence and improve patient survival.

4 Nov 2009

EUSA Pharma's PROSTASCINT effective in guiding targeted prostate cancer treatment

EUSA Pharma announced that PROSTASCINT® (capromab pendetide) fusion imaging was shown to effectively guide prostate cancer therapy targeting and dosing and is a significant predictor of disease free survival, according to data presented on Tuesday, November 3, 2009 at the 51st American Society for Therapeutic Radiology and Oncology (ASTRO) annual meeting in Chicago, Illinois.

4 Nov 2009

Watson Pharmaceuticals announces third quarter 2009 financial results

Watson Pharmaceuticals, Inc. today reported net income of $63.0 million, or $0.55 per diluted share for the third quarter ended September 30, 2009. Excluding special items as detailed in the reconciliation table below, adjusted net income for the third quarter was $76.1 million, or $0.66 per diluted share, an increase of $22.1 million or 41 percent over the adjusted net income for the third quarter ended September 30, 2008. As detailed in the attached reconciliation table, adjusted EBITDA for the third quarter was $178.4 million.

4 Nov 2009

CPEX Pharmaceuticals announces third-quarter results; reports net loss of $872,000

CPEX Pharmaceuticals, Inc. today reported financial results for the third quarter ended September 30, 2009. For the quarter CPEX reported revenues of $5.0 million and a net loss of $872,000.

4 Nov 2009

Comparative study reveals similar brain networks in human and monkey brains

A study published this week in PNAS provides a comprehensive comparative functional anatomy study in human and monkey brains which reveals highly similar brain networks preserved across evolution.

4 Nov 2009

Predictive Biosciences commences clinical trials of its bladder cancer assay

Predictive Biosciences Inc. today announced the publication of pilot study results in the November issue of the Journal of Urology, highlighting the Company’s novel urinary biomarker approach to bladder cancer detection that achieves exceptionally high Negative and Positive Predictive Values (NPV and PPV).

4 Nov 2009

Patients who acquire SSTIs in healthcare settings may stay longer in hospitals to control the infection

Patients who acquire skin and soft tissue infections (SSTIs) in a hospital or other healthcare setting may be more likely to receive inappropriate antibiotic therapy at the beginning of their treatment. As a result, they also may have significantly longer hospital stays to control the infection.

31 Oct 2009

Public concern can undermine flu vaccination campaigns

The effectiveness of pandemic flu vaccination campaigns - like that now underway for H1N1 - could be undermined by the public incorrectly associating coincidental and unrelated health events with the vaccines.

31 Oct 2009

P&G's global branded prescription pharmaceutical business acquired by Warner Chilcott

Warner Chilcott plc announced today it has completed the acquisition of The Procter & Gamble Company's global branded prescription pharmaceutical business. The acquisition complements Warner Chilcott's existing presence in women's health care and adds new therapeutic and geographic markets.

30 Oct 2009

Third-quarter fiscal 2009 results announced by Endo Pharmaceuticals

Endo Pharmaceuticals today reported financial results for the third quarter of 2009.

29 Oct 2009

Cardiome Pharmam, Astellas Pharma begin patient enrolment for ACT 5 trial

Cardiome Pharma Corp. and its co-development partner Astellas Pharma US, Inc. ("Astellas") announced today that patient enrolment has begun for the ACT 5 trial, a confirmatory Phase 3 clinical trial of KYNAPID(TM) (vernakalant hydrochloride) Injection, a drug product candidate under development for the rapid conversion of atrial fibrillation to sinus rhythm.

29 Oct 2009

Urigen Pharmaceuticals announces a presentation on interstitial cystitis/painful bladder syndrome

Urigen Pharmaceuticals, Inc., focused on the development of treatments for urologic disorders and pain, announces a presentation at its offices on October 30, 2009 at 2PM PST. The slides presented will be posted to its website at www.urigen.com after the close of trading that day.

28 Oct 2009

FDA issues clearance for Lumenis' PolyScope Flexible Endoscope

Lumenis Ltd., a global developer, manufacturer and seller of laser, light-based and radiofrequency devices for surgical, aesthetic, and ophthalmic applications, announced that on September 30th, 2009 the FDA issued a 510K to Lumenis stating that the PolyScope Flexible Endoscope can now be sold in the United States.

From Lumenis Inc. 28 Oct 2009

Astellas enters into agreement with Medivation to develop MDV3100

Astellas Pharma Inc. ("Astellas") and Medivation, Inc. announced today that they have entered into a global agreement to develop and commercialize MDV3100, Medivation's investigational drug for the treatment of prostate cancer.

27 Oct 2009

Urology News and Research

Latest Urology News and Research

Study reveals that male factor infertility is associated with a number of medical comorbidities

New technique to identify patients more likely to survive advanced melanoma

Scientific article supports AEterna Zentaris' development of perifosine inhibitor

Warner Chilcott reports a net income of $424.2M for the quarter ended September 30, 2009

Cook Medical to feature a series of product demonstrations in Tokyo, Japan

Changes in PSA over time aid prostate cancer detection

Combination therapy before prostate removal may prevent recurrence of cancer

EUSA Pharma's PROSTASCINT effective in guiding targeted prostate cancer treatment

Watson Pharmaceuticals announces third quarter 2009 financial results

CPEX Pharmaceuticals announces third-quarter results; reports net loss of $872,000

Comparative study reveals similar brain networks in human and monkey brains

Predictive Biosciences commences clinical trials of its bladder cancer assay

Patients who acquire SSTIs in healthcare settings may stay longer in hospitals to control the infection

Public concern can undermine flu vaccination campaigns

P&G's global branded prescription pharmaceutical business acquired by Warner Chilcott

Third-quarter fiscal 2009 results announced by Endo Pharmaceuticals

Cardiome Pharmam, Astellas Pharma begin patient enrolment for ACT 5 trial

Urigen Pharmaceuticals announces a presentation on interstitial cystitis/painful bladder syndrome

FDA issues clearance for Lumenis' PolyScope Flexible Endoscope

Astellas enters into agreement with Medivation to develop MDV3100

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Urology News and Research

Latest Urology News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in